Story excerpt provided by Crain’s Cleveland Business.
Written by Chuck Soder.
Quest Diagnostics announced on Friday, Dec. 1, that it has officially closed a deal to buy Cleveland HeartLab.
Quest, a Fortune 500 medical testing company, announced the deal on Oct. 18. It announced how much it would pay for the company — $94 million in cash — the next day in its third-quarter report.
As part of Quest, Cleveland HeartLab’s local facility will serve as “a national center of excellence” focused on tests related to heart disease, according to a news release announcing the closing of the deal.
Quest also finalized a collaboration with the Cleveland Clinic, which owns a significant stake in Cleveland HeartLab.
Click here to read the complete article.
Originally published December 1, 2017.